Subscribe to Newsletter

Edward Haeggström

CEO, Nanoform

In 2015, Haeggström commercialized the nanoparticle engineering platform he developed with Jouko Yliruusi, acting professor at the University of Helsinki, Finland. This marked the beginning of Nanoform. When asked about what could improve the pharma industry, he responded, “The shift toward a more patient-centric approach in the design of new drugs is something that has been gaining momentum and which I am keen to see more of in the pharma industry. It is my belief that it is not only patients who stand to gain from therapies more tailored to their needs, but also a chance for pharma to grow from both a commercial and humanitarian standpoint. Wider adoption of patient-centric practices and incorporation of patients’ feedback from the early stages of drug discovery through to development has the potential to revolutionize patients’ quality of life. In today’s ever more technologically advanced world, it is easier than ever to achieve.”

Part of the Power List 2021

Find out more

Welcome to our annual celebration of the great and inspirational minds that contribute to the development and manufacture of new medicinal products

Go to The Power List 2021

Part of the Power List 2020

The Power List 2020

Celebrating the great minds that bring us innovation in small molecules, biopharmaceuticals, and advanced medicine.

Go to The Power List 2020

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine